Format

Send to

Choose Destination
Vaccine. 2016 Aug 31;34(38):4467. doi: 10.1016/j.vaccine.2016.03.101.

Response to Letter to the Editor regarding: Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults 18-49 years of age, naive to 23-valent pneumococcal polysaccharide vaccine.

Author information

1
University of Louisville, Louisville, KY, USA. Electronic address: k0brya01@louisville.edu.
2
Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
PMID:
27553746
DOI:
10.1016/j.vaccine.2016.03.101
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center